Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (38 ops.)
Latest filing published 18 Sept 2026 for Revolution Medicines, Inc., €36k. Read the official filing
Filing timeline
BuySaleMark A. Goldsmith
Insider track record
Disclosed buys
0
Disclosed sells
38
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark A. Goldsmith: trading record in brief
Filings by Mark A. Goldsmith span 2 companies, the busiest being Revolution Medicines, Inc. and Constellation Pharmaceuticals Inc. Between 17 June 2021 and 16 September 2026, the trades on record add up to 67 filings.
The open-market record consists of 38 sales worth €38.9M, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 5 share grants and 23 option exercises. In 2026 alone, the filings show no purchases and 23 sales.
On 18 September 2026 came the latest disclosure, an open-market sale for €2.4M in Revolution Medicines, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark A. Goldsmith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations67 total
213 shares@ US$195.0085Common StockSEC:0001246842-26-000008:0
13,775 shares@ US$199.3032Common StockSEC:0001246842-26-000008:1
24,917 shares@ US$208.369711.3% of flowCommon StockSEC:0001610717-26-000387:2
1,351 shares@ US$209.28120.6% of flowCommon StockSEC:0001610717-26-000387:9
126 shares@ US$210.4030.1% of flowCommon StockSEC:0001610717-26-000387:16
1,405 shares@ US$209.26640.6% of flowCommon StockSEC:0001610717-26-000387:15
80,000 shares@ US$4.730.8% of flowCommon StockSEC:0001610717-26-000387:0
5,128 shares@ US$207.2332.3% of flowCommon StockSEC:0001610717-26-000387:1
35,938 shares@ US$209.261516.3% of flowCommon StockSEC:0001610717-26-000387:3
3,813 shares@ US$210.24661.7% of flowCommon StockSEC:0001610717-26-000387:4
6,583 shares@ US$211.33313.0% of flowCommon StockSEC:0001610717-26-000387:5
3,621 shares@ US$212.07761.7% of flowCommon StockSEC:0001610717-26-000387:6
190 shares@ US$207.24540.1% of flowCommon StockSEC:0001610717-26-000387:7
951 shares@ US$208.36480.4% of flowCommon StockSEC:0001610717-26-000387:8
136 shares@ US$210.40170.1% of flowCommon StockSEC:0001610717-26-000387:10
245 shares@ US$211.46510.1% of flowCommon StockSEC:0001610717-26-000387:11
127 shares@ US$212.06350.1% of flowCommon StockSEC:0001610717-26-000387:12
177 shares@ US$207.25150.1% of flowCommon StockSEC:0001610717-26-000387:13
937 shares@ US$208.36090.4% of flowCommon StockSEC:0001610717-26-000387:14
229 shares@ US$211.46480.1% of flowCommon StockSEC:0001610717-26-000387:17
126 shares@ US$212.06410.1% of flowCommon StockSEC:0001610717-26-000387:18
10,020 sharesCommon StockSEC:0001610717-26-000246:0
23,244 shares@ US$4.090.4% of flowCommon StockSEC:0001610717-26-000146:0
96,756 shares@ US$4.732.0% of flowCommon StockSEC:0001610717-26-000146:1
120,000 shares@ US$150.087480.0% of flowCommon StockSEC:0001610717-26-000146:2
25 of 67 declarations
